Identify
AI opportunities aligned with scientific priorities, strategic objectives and operational context.
Bridging scientific challenges with validated AI solutions.
Independent AI Solution Brokerage & Intelligence for biotech and life-science organizations.
TranslAItion Partners helps life-science organizations make better AI decisions through independent evaluation, scientific expertise and evidence-based recommendations.
The AI Evaluation Gap
The AI landscape is expanding faster than most organizations can evaluate.
Biotech and pharma teams face a rapidly growing landscape of AI tools, vendors and platforms. Internally, it is often difficult to compare solutions objectively, assess scientific viability and determine the real value for the organization.
- Too many AI tools and vendor claims to compare with confidence
- Uncertainty around scientific reliability, implementation fit and ROI
- Risk of investing in solutions that do not translate into measurable outcomes
What TranslAItion Partners Does
Independent intelligence between AI innovators and life-science decision makers.
TranslAItion Partners acts as an independent translation and evaluation layer between AI innovators and life-science organizations.
Evaluate
Vendors, technologies and claims compared through an independent scientific lens.
Validate
Pilot design, adoption decisions and long-term intelligence grounded in evidence.
Services
A clear path from opportunity to evaluation, validation and ongoing intelligence.
Assess
AI Opportunity Assessment
A strategic scan to identify relevant AI opportunities within the organization.
Compare
Solution Dossier
An independent dossier evaluating AI solutions, vendors, claims, risks and expected value.
Pilot
Pilot Orchestration
Guidance for structuring, running and assessing AI pilots with clear decision criteria.
Monitor
Quarterly Intelligence
Recurring strategic updates on relevant AI developments, vendors, opportunities and risks.
Cost-to-Outcome Intelligence™
From AI cost to scientific outcome.
AI solutions are evaluated not only on technology or price, but on their contribution to concrete scientific and organizational outcomes.
Scientific Output
Time-to-Insight
Cost Efficiency
Scalability
Adoption Friction
Why TranslAItion Partners
Not another AI vendor. An independent evaluation partner.
Scientific depth
Evaluation shaped by life-science domain expertise and translational experience.
Vendor independence
Recommendations are based on evidence, fit and expected value, not vendor incentives.
Adoption focus
Decisions are connected to implementation realities, team adoption and long-term value.
Founder Profile
Dr. Rogier Reijmers
Dr. Rogier Reijmers is an immunologist and translational scientist with more than twenty years of experience in life sciences, technology evaluation, scientific collaboration and strategic decision-making.
His work brings scientific judgment and practical adoption thinking together, helping organizations separate meaningful AI opportunities from noise.
For Whom
Built for the teams making serious AI adoption decisions in life sciences.
For life-science organizations
- Biotech scale-ups and mid-sized biotech companies
- Pharma innovation teams and R&D leaders
- Strategic decision makers and AI strategy leads
For AI innovators
- AI vendors and platform builders
- Scientific AI startups
- Innovators seeking validation environments and life-science decision makers
Ready to make better AI decisions?
Let's explore where AI can create measurable scientific and strategic value for your organization.
Start a strategic conversation